Ekso Bionics Holdings Inc. announced a total revenue of $1.6 million for the third quarter of 2014, compared to $0.8 million during the third quarter of 2013, according to a company press release.
Third quarter financial results also showed medical device revenue was $0.8 million in 2014 vs. $0.4 million in 2013. Also, engineering revenue was $0.8 million for third quarter of 2014 compared to $0.4 million in the third quarter of 2013.
“I am pleased to share that we have now hit the milestones that we established at the beginning of the year,” Nathan Harding, chief executive office and co-founder of Ekso Bionics Holdings, stated in a press release. “While still very early in our efforts to create a new industry, we see an uptick in Ekso GT shipments, an acceleration of steps taken and growing third party validation of the benefits for robotic neuro-rehabilitation, specifically Ekso Bionics robotic exoskeletons. On the able-bodied front, we see growing possibilities for the development of commercially viable applications for the government and private sector.”